{"title":"Survival and Grades vs. Costs and Values of Nivolumab in Cancer; The Impact of PD-L1 Positivity","authors":"Guirgis Helmy M","doi":"10.36959/825/576","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":92751,"journal":{"name":"Annals of lung cancer","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of lung cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36959/825/576","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
